VHL and nonpapillary renal cell carcinoma: In clear cell RCC (ccRCC) with VHL deletion or mutation, upregulated FTO targets the Gln transporter SLC1A5 to increase the Gln consumption rate and the sustain growth and survival of ccRCC cells.401